Take action to slow GA
![](https://s44478.pcdn.co/wp-content/themes/apellis/images/book-icon.png)
SYFOVRE is the longest-studied treatment to slow GA in as few as 6 doses per year.*
Studied in:
2 clinical trials with
1,200 people and over
10,000 treatments given
*Your doctor will decide how often you receive SYFOVRE (once every 25-60 days).
SYFOVRE was proven to slow lesion growth in people treated with SYFOVRE versus those who were not.
Trial 1
After 2 years, compared to those who did not receive SYFOVRE, SYFOVRE slowed lesion growth by
![](https://s44478.pcdn.co/wp-content/themes/apellis/images/22number.png)
monthly
(n=202)
![](https://s44478.pcdn.co/wp-content/themes/apellis/images/18number.png)
every other month
(n=205)
Trial 2
After 2 years, compared to those who did not receive SYFOVRE, SYFOVRE slowed lesion growth by
![](https://s44478.pcdn.co/wp-content/themes/apellis/images/18number.png)
monthly
(n=201)
![](https://s44478.pcdn.co/wp-content/themes/apellis/images/17number.png)
every other month
(n=201)
SYFOVRE was proven to slow damaging lesion growth over two years with increasing effect over time. The greatest differences were observed in the last 6 months.
GA cannot be cured, and the damage cannot be reversed. However, slowing lesion growth can delay disease progression.
![](https://s44478.pcdn.co/wp-content/themes/apellis/images/what-is-ga-green-bg.png)
![](https://s44478.pcdn.co/wp-content/themes/apellis/images/short-green-brushed.png)
![](https://s44478.pcdn.co/wp-content/themes/apellis/images/short-green-bg.png)